JP2017522319A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017522319A5 JP2017522319A5 JP2017502625A JP2017502625A JP2017522319A5 JP 2017522319 A5 JP2017522319 A5 JP 2017522319A5 JP 2017502625 A JP2017502625 A JP 2017502625A JP 2017502625 A JP2017502625 A JP 2017502625A JP 2017522319 A5 JP2017522319 A5 JP 2017522319A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- amino acid
- acid sequence
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 48
- 229920001184 polypeptide Polymers 0.000 claims description 46
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 46
- 101710186862 Factor H binding protein Proteins 0.000 claims description 16
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 14
- 230000004927 fusion Effects 0.000 claims description 14
- 239000012528 membrane Substances 0.000 claims description 8
- 230000002163 immunogen Effects 0.000 claims description 7
- 241000124008 Mammalia Species 0.000 claims description 4
- 241000699670 Mus sp. Species 0.000 claims description 4
- 125000001433 C-terminal amino-acid group Chemical group 0.000 claims description 2
- 208000034762 Meningococcal Infections Diseases 0.000 claims description 2
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims description 2
- 241000588650 Neisseria meningitidis Species 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- -1 linker amino acid Chemical class 0.000 claims description 2
- 238000000034 method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14177563.5 | 2014-07-17 | ||
| EP14177563 | 2014-07-17 | ||
| PCT/EP2015/066229 WO2016008961A1 (en) | 2014-07-17 | 2015-07-16 | Meningococcus vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020066808A Division JP7074793B2 (ja) | 2014-07-17 | 2020-04-02 | 髄膜炎菌ワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017522319A JP2017522319A (ja) | 2017-08-10 |
| JP2017522319A5 true JP2017522319A5 (enExample) | 2018-08-23 |
| JP6687597B2 JP6687597B2 (ja) | 2020-04-22 |
Family
ID=51178811
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017502625A Active JP6687597B2 (ja) | 2014-07-17 | 2015-07-16 | 髄膜炎菌ワクチン |
| JP2020066808A Active JP7074793B2 (ja) | 2014-07-17 | 2020-04-02 | 髄膜炎菌ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020066808A Active JP7074793B2 (ja) | 2014-07-17 | 2020-04-02 | 髄膜炎菌ワクチン |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11707513B2 (enExample) |
| EP (1) | EP3169358A1 (enExample) |
| JP (2) | JP6687597B2 (enExample) |
| KR (2) | KR20230012100A (enExample) |
| CN (2) | CN113827712A (enExample) |
| AR (2) | AR101225A1 (enExample) |
| AU (2) | AU2015289193A1 (enExample) |
| BE (1) | BE1022878B1 (enExample) |
| BR (1) | BR112017000519A2 (enExample) |
| CA (1) | CA2954729C (enExample) |
| EA (1) | EA038940B1 (enExample) |
| IL (1) | IL249823B (enExample) |
| MX (1) | MX2017000775A (enExample) |
| SG (2) | SG10201900041VA (enExample) |
| WO (1) | WO2016008961A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6786394B2 (ja) | 2014-02-28 | 2020-11-18 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 改変髄膜炎菌ｆＨｂｐポリペプチド |
| EA201692552A1 (ru) | 2014-07-17 | 2017-06-30 | Глаксосмитклайн Байолоджикалс С.А. | МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp |
| CA2954729C (en) | 2014-07-17 | 2023-08-22 | Glaxosmithkline Biologicals S.A. | Meningococcus vaccines |
| WO2017075189A1 (en) * | 2015-10-27 | 2017-05-04 | University Of Massachusetts | Factor h-fc immunotherapy |
| CN107961369B (zh) * | 2017-03-22 | 2020-08-11 | 武汉博沃生物科技有限公司 | 多价脑膜炎球菌缀合疫苗及其制备方法 |
| CN108939061A (zh) * | 2018-08-03 | 2018-12-07 | 北京智飞绿竹生物制药有限公司 | 一种多组分b群脑膜炎球菌疫苗及其制备方法 |
| EP3607967A1 (en) * | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Modified meningococcal fhbp polypeptides |
| US11014736B2 (en) | 2019-04-18 | 2021-05-25 | Altria Client Services Llc | Sliding packs with flip top hinged lids |
| CN110804101A (zh) * | 2019-11-08 | 2020-02-18 | 苏州微超生物科技有限公司 | B群脑膜炎球菌相关融合蛋白、疫苗及其制备方法与应用 |
| CN115348968A (zh) * | 2019-11-25 | 2022-11-15 | 格里菲斯大学 | 针对淋球菌感染的免疫原性蛋白 |
| GB202115151D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Methods |
| WO2025077785A1 (zh) * | 2023-10-10 | 2025-04-17 | 康希诺生物股份公司 | 一种抗脑膜炎球菌的免疫组合物及其用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6747137B1 (en) | 1998-02-13 | 2004-06-08 | Genome Therapeutics Corporation | Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics |
| US6551795B1 (en) | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
| ES2507100T3 (es) * | 2000-01-17 | 2014-10-14 | Novartis Vaccines And Diagnostics S.R.L. | Vacuna OMV suplementada contra meningococo |
| GB0227346D0 (en) * | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| GB0419408D0 (en) * | 2004-09-01 | 2004-10-06 | Chiron Srl | 741 chimeric polypeptides |
| GB0419627D0 (en) * | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
| GB0524066D0 (en) * | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| AU2010310985B2 (en) | 2009-10-27 | 2014-11-06 | Glaxosmithkline Biologicals S.A. | Modified meningococcal fHBP polypeptides |
| US9567377B2 (en) * | 2010-03-10 | 2017-02-14 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| CN105315351A (zh) | 2010-03-30 | 2016-02-10 | 奥克兰儿童医院及研究中心 | 改性的h因子结合蛋白（fhbp）及其使用方法 |
| GB201015132D0 (en) | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
| GB201120634D0 (en) | 2011-11-30 | 2012-01-11 | Univ Sheffield | Adjuvant polypeptide |
| JP2015521595A (ja) * | 2012-06-14 | 2015-07-30 | ノバルティス アーゲー | 血清群ｘ髄膜炎菌のためのワクチン |
| GB201215005D0 (en) | 2012-08-23 | 2012-10-10 | Isis Innovation | Stabilised meningitis vaccine |
| JP6786394B2 (ja) * | 2014-02-28 | 2020-11-18 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 改変髄膜炎菌ｆＨｂｐポリペプチド |
| EP2916512B1 (en) | 2014-03-07 | 2016-08-24 | Mitsubishi Electric R&D Centre Europe B.V. | Method for classifying a TCP connection carrying HTTP traffic as a trusted or an untrusted TCP connection |
| CA2954729C (en) | 2014-07-17 | 2023-08-22 | Glaxosmithkline Biologicals S.A. | Meningococcus vaccines |
| EA201692552A1 (ru) | 2014-07-17 | 2017-06-30 | Глаксосмитклайн Байолоджикалс С.А. | МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp |
| ES2990193T3 (es) | 2018-06-21 | 2024-11-29 | Basf Se | Derivados de difosfato de 3-fenilbenzofuran-2-ona como estabilizadores |
-
2015
- 2015-07-16 CA CA2954729A patent/CA2954729C/en active Active
- 2015-07-16 KR KR1020237001115A patent/KR20230012100A/ko not_active Ceased
- 2015-07-16 BR BR112017000519A patent/BR112017000519A2/pt not_active Application Discontinuation
- 2015-07-16 EA EA201692554A patent/EA038940B1/ru unknown
- 2015-07-16 CN CN202111134597.5A patent/CN113827712A/zh active Pending
- 2015-07-16 SG SG10201900041VA patent/SG10201900041VA/en unknown
- 2015-07-16 CN CN201580038773.1A patent/CN106659776A/zh active Pending
- 2015-07-16 KR KR1020177004245A patent/KR102626831B1/ko active Active
- 2015-07-16 WO PCT/EP2015/066229 patent/WO2016008961A1/en not_active Ceased
- 2015-07-16 JP JP2017502625A patent/JP6687597B2/ja active Active
- 2015-07-16 MX MX2017000775A patent/MX2017000775A/es unknown
- 2015-07-16 US US15/319,665 patent/US11707513B2/en active Active
- 2015-07-16 IL IL249823A patent/IL249823B/en unknown
- 2015-07-16 EP EP15738900.8A patent/EP3169358A1/en active Pending
- 2015-07-16 AR ARP150102269A patent/AR101225A1/es not_active Application Discontinuation
- 2015-07-16 SG SG11201610946YA patent/SG11201610946YA/en unknown
- 2015-07-16 BE BE2015/5455A patent/BE1022878B1/fr not_active IP Right Cessation
- 2015-07-16 AU AU2015289193A patent/AU2015289193A1/en not_active Abandoned
-
2019
- 2019-02-18 AU AU2019201131A patent/AU2019201131C1/en active Active
-
2020
- 2020-04-02 JP JP2020066808A patent/JP7074793B2/ja active Active
-
2023
- 2023-06-06 US US18/329,701 patent/US12485164B2/en active Active
- 2023-10-17 AR ARP230102768A patent/AR130778A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017522319A5 (enExample) | ||
| RU2015122368A (ru) | Слитые белки для применения в качестве иммуногенных усиливающих агентов для индуцирования антигенспецифического т-клеточного ответа | |
| Yano et al. | An ingenious design for peptide vaccines | |
| JP2014503172A5 (enExample) | ||
| RU2015139827A (ru) | МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHBP | |
| JP2008530245A5 (enExample) | ||
| JP2015212284A5 (enExample) | ||
| WO2020234300A1 (en) | A subunit vaccine for treatment or prevention of a respiratory tract infection | |
| JP2016196472A5 (enExample) | ||
| TW201408691A (zh) | 分枝桿菌抗原疫苗 | |
| HRP20161710T1 (hr) | Identifikacija, optimizacija i uporaba kriptičkih hla-a24 etiopa za imunoterapiju | |
| PT1651166E (pt) | Polipeptidos para indução de uma resposta imunitária de protecção contra staphylococcus aureus | |
| JP2019526274A5 (enExample) | ||
| WO2009099777A3 (en) | Chimeric hiv fusion proteins as vaccines | |
| UA107180C2 (uk) | Туберкульозний білок rv1753c, композиція, що його містить, та застосування | |
| KR20160088323A (ko) | S. 뉴모니에(S. pneumoniae)에 대항하는 보호성 프롤린-풍부한 펩티드 | |
| RU2016108139A (ru) | Композиция neisseria meningitidis и способ индуцирования иммунного ответа | |
| RU2015100889A (ru) | Вакцины для менингококка серогруппы х | |
| Vadesilho et al. | Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae | |
| US20230399364A1 (en) | Immunogenic Coronavirus Fusion Proteins and Related Methods | |
| EP3818989A1 (en) | Peptides and oligonucleotides for a sars-cov-2 vaccine | |
| EP3302543A1 (en) | Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases | |
| WO2009129521A3 (en) | Immunodominant mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization | |
| JP2010535504A5 (enExample) | ||
| JP2016515516A5 (enExample) |